Intravenous Dose-Escalation Study With ETI-204 in Adult Volunteers
NCT00829582
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
ETI-204, "Anthim"
OTHER:
placebo
Sponsor
Elusys Therapeutics